Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion type Assertion NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_head.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion description "[Here, we show that RUNX1-ETO undergoes degradation in response to treatment with histone deacetylase inhibitors, one of which, depsipeptide (DEP), is currently undergoing phase II clinical testing in a variety of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_provenance.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion evidence source_evidence_literature NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_provenance.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion SIO_000772 16799637 NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_provenance.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion wasDerivedFrom befree-20140225 NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_provenance.
- NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_assertion wasGeneratedBy ECO_0000203 NP817330.RAXfMu1ZIMq0fas0icR6STHGGzQ2Mc5jJsYgnJCtWNHIo130_provenance.